Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sloan Sheldon
Spyre Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Sloan Sheldon
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burrows Scott L
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.963%),Abigail P. Johnson(12.963%)
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stelzer Laurie
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Milligan Sandra
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENDERSON MICHAEL THOMAS
Spyre Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Milligan Sandra
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Spyre Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Harwin(11.17%),Tomas Kiselak(11.17%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(5.1%),Behzad Aghazadeh(5.1%)
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(18.213%),Abigail P. Johnson(18.213%)
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Turtle Cameron
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(5.4%),Commodore Capital Master LP(5.4%)
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(0.0%),Baker Bros. Advisors (GP) LLC(0.0%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(2.5%),Oleg Nodelman(2.5%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(0%),Wilmot B. Harkey(0%), etc.
No Data
No Data